Introduction
Despite the extensive knowledge that has accumulated on the biochemistry, serology and epidemiology of the influenza A virus, surprisingly little is known of the mechanisms of host defence against influenza infection. In man, the epidemiological findings are conflicting, and the evidence available is mainly relevant to serological correlates of immunity rather than to the mechanisms involved in protection (Stuart-Harris, 1972) . The experimental animal lends itself to investigation of the important question of the respective role of humoral versus cell-mediated immunity in protection against influenza infection. Using an avian model, a study involving bursectomy and thymectomy suggested that cell-mediated immunity is less important than humoral immunity in recovery from infection (Portnoy, Bloom and Merigan, 1973) . In mice, it has been shown that passive transfer of post-infection immune serum can protect against influenza infection (Loosli, Hamre and Berlin, 1953) and that transfer of anti-neuraminidase antibody is also protective (Schulman, Khakpour and Kilbourne, 1968) . However, unequivocal evidence for a humoral mechanism for resistance would be provided by the observation that serum antibody transferred to susceptible individuals in concentrations found in animals immunized by natural infection can passively protect both normal and immunodepressed recipients. Using this approach in either normal, cyclophosphamide-treated, or thymusdeprived animals, we have shown that physiological amounts of specific antibodies, especially those directed against haemagglutinin, protect in the absence of an active host response (Virelizier, 1975) . The essential role of antibody to external antigens of the virus is further underlined by our finding that mice actively or passively immunized against internal components of influenza A virus are not significantly protected (Oxford and Schild, 1976 ).
Materials and methods Mice
Adult CBA mice 6-8 weeks old were used. Thymusdeprived, irradiated, and bone marrow reconstituted animals (TXBM) were obtained as described previously (Virelizier, 1975) . Normal control mice (T +) were untreated animals from the same batch.
Cyclophosphamide (CY) treatment
Mice were injected intraperitoneally (i.p.) with a sublethal dose (300 mg/kg) of cyclophosphamide (Endoxana, Ward Blenkinsop, London). The techniques used for transfer of spleen cells, detection of viruses in mouse organs, and intranasal inoculation, have been described previously (Virelizier, 1975) .
Measurement of antibody
This was done by the single radial immunodiffusion method as described by Schild, HenryAymard and Pereira (1972) . A purified concentrated preparation of intact A/PR8/34 (HoN1) virus was mixed in agarose at a final concentration of 0 15 mg of viral proteins/ml. Antibody potency was measured by the annulus area (mm2) of the zone of opalescence appearing around 2 mm diameter wells containing 5 ,ul volumes of test antiserum.
Viruses
The virus stains employed, the purification of their haemagglutinins and preparation of antiinfluenza virus or anti-haemagglutinin antisera have been described previously (Virelizier, 1975 (Laver, 1964) and matched up to the original strip. Under these conditions the M protein was contained in a well demarcated band moving most rapidly to the anode. The protein from ten strips was eluted at 4°C overnight into 5 ml of PBS, dialysed against PBS for 2 days at 4°C to remove detergent and used as antigen. Preparations were analysed by SDS polyacrylamide gel electrophoresis to verify absence of other virus polypeptides (Oxford, 1973) . Nucleoprotein antigen was contained in a protein band moving more slowly towards the anode behind the MP band under the above conditions and was similarly located, eluted from the strips, dialysed and stored at -70°C until used as antigen (Oxford and Schild, 1976) .
Results
Transfer of immune spleen cells Table 1 shows that transfer of spleen cells from immune resistant donors into susceptible gnotobiotic Absence of protection in mice actively or passively immunized against M or NP antigens
As shown in Table 3 , transfer of potent rabbit antisera to MP or NP, the two major internal components of influenza A viruses, did not protect against an A/PR8 infection. In addition, transfer of a mixture of anti-M and anti-NP antibody did not provide any detectable protection. Moreover, active immunization with these two structural antigens also failed to confer protection to a lethal challenge with A/PR8 virus, as shown in Table 4 . Protection ofcyclophosphamide-treated mice by transferred antibodies Table 5 shows that mice receiving CY 18 hr after infection with a dose of A/PR8 virus, which was nonlethal in normal untreated mice, did not produce detectable antibody 7 days after infection and died. Other groups of mice were injected, 24 hr after infection, with a dose of rabbit antiserum found empirically to provide in recipients titres of serum antibodies similar to those observed in intact animals 7 days after infection. It was shown that while recipients of anti-A/PR8 and anti-A/FM1 virus (whole particles) were equally protected, there was a striking difference between the animals receiving anti-H1 antibody, which all died, and the animals receiving anti-H0 antibody, which all survived.
Protection of thymus-deprived mice by transferred anti-HO antibody Figure 1 shows that thymus deprivation potentiates influenza A infection and decreases serum antibody levels, especially in mice (approximately 50%. in repeated experiments) which died before day 21. TXBM mice remaining alive at day 21 after infection still had detectable influenza virus in the brain and lungs, at a time when organ suspensions from infected control mice were negative. Transfer of antibody to Ho 24 hr after infection in TXBM mice was effective in protecting against death and in clearing the virus in both brain and lung, as shown in Table 6 .
Discussion
The results reported in the present communication suggest that humoral immunity is more important than cellular immunity in protection against influenza A virus infection in mice. Recipients of immune spleen cells were very poorly protected against a lethal challenge with A/PR8 virus. This was not due to inefficient transfer of immunity, since the presence of both thymus-derived (T) and bonemarrow derived (B) to be fully protected, indicating that immune spleen cells are fully protective only when they secrete antibody. Conversely, it has been found that CY treatment prevents the anti-influenza antibody response and potentiates influenza infection. This finding apparently conflicts with reports that CY (Singer, Noguchi and Kirschstein, 1972) or anti-lymphocytic serum treatment (Suzuki, Ohya and Ishida, 1974 ) may lead to a less severe disease in influenza-infected mice. However, experimental conditions may be critical, and immunosuppression may decrease antibody production in some systems, and decrease the cellular recruitment, thereby minimizing the resultant harmful lung consolidation in others. Indeed a recent publication (Hurd and Heath, 1975) reconciles these different data by showing that CY increases the mortality of mice infected with low concentrations of influenza virus, but delays the time of death in mice infected with high concentrations of the same variant. The finding that transfer of serum antibody, resulting in serum titres in the recipients comparable to those found in mice which will later recover from infection, can protect both normal and immunosuppressed mice, strongly suggests that humoral immunity plays a major role in protection under natural conditions. Since the analysis of the authors' hyperimmune rabbit antisera by rate centrifugation in sucrose gradients showed that they contained exclusively 7S anti-influenza immunoglobulins, it can be assumed that IgG antibody was in fact protective in their method. While the role of respiratory IgA remains speculative, the results suggest that IgG molecules are efficient against a pulmonary infection. This is in agreement with reports that in ferrets (Shore, Potter and McLaren, 1972) as well as in horses (Rouse and Ditchfield, 1970 ) the nasal antibody to influenza virus appears to be a 7S IgG protein.
In our study, the specificity of the transferred antibody was apparently critical. Antibody to internal components of the influenza virus (M and NP) appeared to have no relevance to protection in our system, even when given in large amounts. This appears to conflict with the finding (Schulman and Kilbourne, 1965; Werner, 1966; Kurimura, Hirano and Okuno, 1973; Oxford and Schild, unpublished observations) that intratypic cross-immunity can be found in mice previously infected with A/HK/1/68 (H3N2) and challenged with A/PR8/34 (HoN,).
However, in post-infection sera, antibodies with as yet unrecognized specificity may contribute to protection, as suggested by other authors (Masurel, Baars and Frankena, 1973; Sweet, Stephen and Smith, 1974) . In contrast to the absence of protection with antibody to internal structural antigens, transfer of antibody to external components proved highly effective. Anti-neuraminidase antibody appeared less effective, however, than anti-haemagglutinin antibody. In a previous communication evidence was provided that Ho and H1 haemagglutinins share common antigenic determinants eliciting cross-reacting (CR) antibodies, but differ in their strain-specific determinants eliciting a strain-specific population of antibodies (called SO in the case of an anti-H0 response). Our results suggest that SO antibodies have a much better protective efficiency than CR antibodies. This finding is in accordance with the relative inefficacy in man of influenza vaccines containing previously prevalent influenza virus strains rather than the current prevalent virus.
These findings do not rule out the possibility that cell-mediated immunity plays an active role in host defence against influenza virus infection under natural conditions. Indeed, it has previously been reported that antibody formation to influenza haemagglutinin is impaired in thymus-deprived mice, the secretion of strain-specific antibody being especially thymusdependent . Moreover, it has been shown that T cells regulate the production of anti-haemagglutinin antibodies by either enhancing or suppressing their secretion by B memory cells . The present study confirms that infected TXBM animals indeed had a decreased antibody response and a higher mortality than the controls. This suggests that T lymphocytes may have an indirect but essential role 336 Oi group.bmj.com on July 6, 2017 -Published by http://pmj.bmj.com/ Downloaded from in host defences against influenza infection by enhancing the secretion of protective strain-specific anti-haemagglutinin antibodies.
